Elucidation of lipoprotein particles structure by proteomic analysis

Lipoproteins are responsible for lipid packaging and transport through the bloodstream, and for their delivery to target tissues. Their participation in process, such as inflammation and innate immunity has also been suggested recently. Lipoprotein particles have very complex biochemical structures, which result from intricate processes involving coordinated mechanisms of protein and lipid synthesis, intracellular assembling and trafficking, and intra- and extracellular metabolism. Alterations in these mechanisms cause several negative effects on human health. The ability of current proteomic approaches to dissect the dynamic nature of complex particles revealing protein composition and post-translational modifications is shedding further light on lipoprotein structures and functions. This review summarizes lipoprotein classification, biogenesis and metabolism as well as discussing how the results of 20 proteomics-based reports integrate our knowledge on both their biochemical composition and their effects on target cells, thus contributing to reveal the possible functions.

[1]  B. Fagerberg,et al.  Proteomics and lipids of lipoproteins isolated at low salt concentrations in D2O/sucrose or in KBr Published, JLR Papers in Press, November 18, 2007. , 2008, Journal of Lipid Research.

[2]  K. Orino,et al.  Apolipoprotein B binds ferritin by hemin-mediated binding: evidence of direct binding of apolipoprotein B and ferritin to hemin , 2008, BioMetals.

[3]  D. Hommes,et al.  Enhanced atherogenesis and altered high density lipoprotein in patients with Crohn's disease Published, JLR Papers in Press, September 22, 2007. , 2007, Journal of Lipid Research.

[4]  R. Lehner,et al.  Proteomic and Lipid Characterization of Apolipoprotein B-free Luminal Lipid Droplets from Mouse Liver Microsomes , 2007, Journal of Biological Chemistry.

[5]  F. Rezaee,et al.  SELDI-TOF mass spectrometry of High-Density Lipoprotein , 2007, Proteome Science.

[6]  S. Hazen,et al.  Platelet CD36 links hyperlipidemia, oxidant stress and a prothrombotic phenotype , 2007, Nature Medicine.

[7]  Chii‐Ming Lee,et al.  Proteomic approach to study the effects of various oxidatively modified low-density lipoprotein on regulation of protein expression in human umbilical vein endothelial cell. , 2007, Life sciences.

[8]  M. Heller,et al.  Compositional Protein Analysis of High Density Lipoproteins in Hypercholesterolemia by Shotgun LC-MS/MS and Probabilistic Peptide Scoring*S , 2007, Molecular & Cellular Proteomics.

[9]  Subramaniam Pennathur,et al.  Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL. , 2007, The Journal of clinical investigation.

[10]  A. Hill,et al.  Role of ABCG1 and ABCA1 in Regulation of Neuronal Cholesterol Efflux to Apolipoprotein E Discs and Suppression of Amyloid-β Peptide Generation* , 2007, Journal of Biological Chemistry.

[11]  D. Rader.  Molecular regulation of HDL metabolism and function: implications for novel therapies. , 2006, The Journal of clinical investigation.

[12]  A. Watson,et al.  Thematic Review Lipidomics: a Global Approach to Lipid Analysis in Biological Systems , 2022 .

[13]  H. Lindqvist,et al.  Characterization of apolipoprotein M isoforms in low-density lipoprotein. , 2006, Journal of proteome research.

[14]  Aldons J. Lusis,et al.  A thematic review series: systems biology approaches to metabolic and cardiovascular disorders , 2006, Journal of Lipid Research.

[15]  J. Spence.  Lipoprotein(a): involved in events, but not burden of atherosclerotic disease? , 2006, Stroke.

[16]  A. Tall,et al.  LXR-Induced Redistribution of ABCG1 to Plasma Membrane in Macrophages Enhances Cholesterol Mass Efflux to HDL , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[17]  Albert K Groen,et al.  Intestinal ABCA1 directly contributes to HDL biogenesis in vivo. , 2006, The Journal of clinical investigation.

[18]  J. Kastelein,et al.  Cholesteryl ester transfer protein (CETP) inhibition beyond raising high-density lipoprotein cholesterol levels: pathways by which modulation of CETP activity may alter atherogenesis. , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[19]  G. Hortin,et al.  Diverse range of small peptides associated with high-density lipoprotein. , 2006, Biochemical and biophysical research communications.

[20]  T. Huh,et al.  Proteome analysis of human monocytic THP‐1 cells primed with oxidized low‐density lipoproteins , 2006, Proteomics.

[21]  D. Giugliano,et al.  Inflammation warms up the metabolic syndrome. , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[22]  Michael Kinter,et al.  Proteomic and Transcriptomic Analyses of Macrophages with an Increased Resistance to Oxidized Low Density Lipoprotein (oxLDL)-induced Cytotoxicity Generated by Chronic Exposure to oxLDL* , 2005, Molecular & Cellular Proteomics.

[23]  B. Fagerberg,et al.  A proteomic study of the apolipoproteins in LDL subclasses in patients with the metabolic syndrome and type 2 diabetes Published, JLR Papers in Press, July 1, 2005. DOI 10.1194/jlr.M500161-JLR200 , 2005, Journal of Lipid Research.

[24]  M. Mann,et al.  Exponentially Modified Protein Abundance Index (emPAI) for Estimation of Absolute Protein Amount in Proteomics by the Number of Sequenced Peptides per Protein*S , 2005, Molecular & Cellular Proteomics.

[25]  R. Brasseur,et al.  Apolipoprotein L-I Promotes Trypanosome Lysis by Forming Pores in Lysosomal Membranes , 2005, Science.

[26]  D. Corella,et al.  SINGLE NUCLEOTIDE POLYMORPHISMS THAT INFLUENCE LIPID METABOLISM: Interaction with Dietary Factors. , 2005, Annual review of nutrition.

[27]  D. Rader,et al.  New Insights Into the Regulation of HDL Metabolism and Reverse Cholesterol Transport , 2005, Circulation research.

[28]  N. Davidson,et al.  CD36 deficiency impairs intestinal lipid secretion and clearance of chylomicrons from the blood. , 2005, The Journal of clinical investigation.

[29]  M. Hayden,et al.  Targeted inactivation of hepatic Abca1 causes profound hypoalphalipoproteinemia and kidney hypercatabolism of apoA-I. , 2005, The Journal of clinical investigation.

[30]  Per Leanderson,et al.  Lipoproteomics II: Mapping of proteins in high‐density lipoprotein using two‐dimensional gel electrophoresis and mass spectrometry , 2005, Proteomics.

[31]  P. Delafontaine,et al.  Protein chip‐based microarray profiling of oxidized low density lipoprotein‐treated cells , 2005, Proteomics.

[32]  Xianlin Han,et al.  Shotgun lipidomics: multidimensional MS analysis of cellular lipidomes , 2005, Expert review of proteomics.

[33]  E. Niki,et al.  Proteomic characterization of oxidative dysfunction in human umbilical vein endothelial cells (HUVEC) induced by exposure to oxidized LDL , 2005, Free radical research.

[34]  D. Ng.  Insight into the Role of LCAT from Mouse Models , 2004, Reviews in Endocrine and Metabolic Disorders.

[35]  B. Behrendt,et al.  Scavenger Receptor Class B Type I Mediates the Selective Uptake of High-Density Lipoprotein–Associated Cholesteryl Ester by the Liver in Mice , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[36]  G. Gibbons,et al.  Synthesis and function of hepatic very-low-density lipoprotein. , 2004, Biochemical Society transactions.

[37]  S. Chuck,et al.  Ferritins Can Regulate the Secretion of Apolipoprotein B* , 2003, Journal of Biological Chemistry.

[38]  R. Macfarlane,et al.  Analysis of high-density lipoprotein apolipoproteins recovered from specific immobilized pH gradient gel pI domains by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. , 2003, Analytical chemistry.

[39]  G. Assmann,et al.  Apolipoprotein C-III, a strong discriminant of coronary risk in men and a determinant of the metabolic syndrome in both genders. , 2003, Atherosclerosis.

[40]  R. Brasseur,et al.  Apolipoprotein L-I is the trypanosome lytic factor of human serum , 2003, Nature.

[41]  Xavier Collet,et al.  Ectopic β-chain of ATP synthase is an apolipoprotein A-I receptor in hepatic HDL endocytosis , 2003, Nature.

[42]  M. Hussain,et al.  Microsomal triglyceride transfer protein and its role in apoB-lipoprotein assembly Published, JLR Papers in Press, September 16, 2002. DOI 10.1194/jlr.R200014-JLR200 , 2003, Journal of Lipid Research.

[43]  D. Ramji,et al.  Lipoprotein lipase: structure, function, regulation, and role in disease , 2002, Journal of Molecular Medicine.

[44]  P. Bondarenko,et al.  MALDI- and ESI-MS of the HDL apolipoproteins; new isoforms of apoA-I, II , 2002 .

[45]  J. Vance,et al.  Microsomal Triacylglycerol Transfer Protein Is Required for Lumenal Accretion of Triacylglycerol Not Associated with ApoB, as Well as for ApoB Lipidation* , 2002, The Journal of Biological Chemistry.

[46]  L. Martinez,et al.  Hepatic lipase: structure/function relationship, synthesis, and regulation. , 2002, Journal of lipid research.

[47]  S. Chuck,et al.  A Proteomic Approach Identifies Proteins in Hepatocytes That Bind Nascent Apolipoprotein B* , 2002, The Journal of Biological Chemistry.

[48]  A. Tall,et al.  High Density Lipoprotein (HDL) Particle Uptake Mediated by Scavenger Receptor Class B Type 1 Results in Selective Sorting of HDL Cholesterol from Protein and Polarized Cholesterol Secretion* , 2001, The Journal of Biological Chemistry.

[49]  G. Chisolm,et al.  Oxidized LDL-induced injury and apoptosis in atherosclerosis. Potential roles for oxysterols. , 2001, Trends in cardiovascular medicine.

[50]  M. Pfeffer,et al.  VLDL, Apolipoproteins B, CIII, and E, and Risk of Recurrent Coronary Events in the Cholesterol and Recurrent Events (CARE) Trial , 2000, Circulation.

[51]  C. Gabel,et al.  High density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP-binding cassette transporter-1. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[52]  C. Packard,et al.  Apolipoprotein B overproduction by the perfused liver of the St. Thomas' mixed hyperlipidemic (SMHL) rabbit. , 1999, Journal of lipid research.

[53]  P. Bondarenko,et al.  Mass spectral study of polymorphism of the apolipoproteins of very low density lipoprotein. , 1999, Journal of lipid research.

[54]  H. Herscovitz,et al.  Multiple Molecular Chaperones Interact with Apolipoprotein B during Its Maturation , 1998, The Journal of Biological Chemistry.

[55]  A. Rigotti,et al.  A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[56]  E. Edelman,et al.  Overexpression of the HDL receptor SR-BI alters plasma HDL and bile cholesterol levels , 1997, Nature.

[57]  G. Assmann,et al.  The molecular pathology of lecithin:cholesterol acyltransferase (LCAT) deficiency syndromes. , 1997, Journal of lipid research.

[58]  J. Breslow,et al.  Dramatically decreased high density lipoprotein cholesterol, increased remnant clearance, and insulin hypersensitivity in apolipoprotein A-II knockout mice suggest a complex role for apolipoprotein A-II in atherosclerosis susceptibility. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[59]  Ann Smith,et al.  Role of hemopexin in protection of low-density lipoprotein against hemoglobin-induced oxidation. , 1996, Biochemistry.

[60]  R. Pease,et al.  Regulation of hepatic apolipoprotein-B-containing lipoprotein secretion , 1996, Current opinion in lipidology.

[61]  S. Cockcroft.  ARF-regulated phospholipase D: a potential role in membrane traffic. , 1996, Chemistry and physics of lipids.

[62]  K. Williams,et al.  The response-to-retention hypothesis of early atherogenesis. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[63]  D. Rader,et al.  Cloning and gene defects in microsomal triglyceride transfer protein associated with abetalipoproteinaemia , 1993, Nature.

[64]  H. Hobbs,et al.  Molecular definition of the extreme size polymorphism in apolipoprotein(a). , 1993, Human molecular genetics.

[65]  N. Maeda,et al.  Marked reduction of high density lipoprotein cholesterol in mice genetically modified to lack apolipoprotein A-I. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[66]  D. Russell.  Cholesterol biosynthesis and metabolism , 1992, Cardiovascular Drugs and Therapy.

[67]  A. Tall,et al.  Reduced high density lipoprotein cholesterol in human cholesteryl ester transfer protein transgenic mice. , 1991, The Journal of biological chemistry.

[68]  A. Tall,et al.  Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation. , 1990, The New England journal of medicine.

[69]  G. Bondjers,et al.  Differential uptake of proteoglycan-selected subfractions of low density lipoprotein by human macrophages. , 1990, Journal of lipid research.

[70]  A. Tall,et al.  Molecular basis of lipid transfer protein deficiency in a family with increased high-density lipoproteins , 1989, Nature.

[71]  E. Chen,et al.  cDNA sequence of human apolipoprotein(a) is homologous to plasminogen , 1987, Nature.

[72]  D. Steinberg,et al.  Macrophage Oxidation of Low Density Lipoprotein Generates a Modified Form Recognized by the Scavenger Receptor , 1986, Arteriosclerosis.

[73]  C. S. Wang,et al.  Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III. , 1985, The Journal of clinical investigation.

[74]  F. Field,et al.  beta-sitosterol: esterification by intestinal acylcoenzyme A: cholesterol acyltransferase (ACAT) and its effect on cholesterol esterification. , 1983, Journal of lipid research.

[75]  D. Steinberg,et al.  Enhanced Macrophage Degradation of Biologically Modified Low Density Lipoprotein , 1983, Arteriosclerosis.

[76]  K. Berg,et al.  The apoE polymorphism studied by two‐dimensional, high‐resolution gel electrophoresis of serum , 1981, Clinical genetics.

[77]  J. Breslow,et al.  Human very low density lipoprotein apolipoprotein E isoprotein polymorphism is explained by genetic variation and posttranslational modification. , 1981, Biochemistry.

[78]  P. Kinnunen,et al.  Lipolysis of ApoC-II deficient very low density lipoproteins: enhancement of lipoprotein lipase action by synthetic fragments of apoC-II. , 1979, Biochemical and biophysical research communications.

[79]  J. Řeřábek.  Two-dimensional immunoelectrophrophoretic pattern of low- and very-low-density lipoproteins, with particular reference to Fredrickson's type III. , 1977, Clinical chemistry.

[80]  A. L. Latner,et al.  The separation of plasma lipoproteins using gel electrofocusing and polyacrylamide gradient gel electrophoresis. , 1976, Clinica chimica acta; international journal of clinical chemistry.

[81]  V. Shore,et al.  Heterogeneity in protein subunits of human serum high-density lipoproteins. , 1968, Biochemistry.

[82]  P. Alaupovic,et al.  STUDIES OF THE COMPOSITION AND STRUCTURE OF SERUM LIPOPROTEINS: ISOLATION, PURIFICATION, AND CHARACTERIZATION OF VERY LOW DENSITY LIPOPROTEINS OF HUMAN SERUM. , 1965, Biochemistry.

[83]  G. Fimia,et al.  Proteomic analysis of human very low‐density lipoprotein by two‐dimensional gel electrophoresis and MALDI‐TOF/TOF , 2007, Proteomics.

[84]  Farhad Rezaee,et al.  Proteomic analysis of high‐density lipoprotein , 2006, Proteomics.

[85]  P. Leanderson,et al.  Lipoproteomics I: Mapping of proteins in low‐density lipoprotein using two‐dimensional gel electrophoresis and mass spectrometry , 2005, Proteomics.

[86]  J. Berliner,et al.  A role for oxidized phospholipids in atherosclerosis. , 2005, The New England journal of medicine.

[87]  M. Krieger.  Charting the fate of the "good cholesterol": identification and characterization of the high-density lipoprotein receptor SR-BI. , 1999, Annual review of biochemistry.

[88]  G. Bondjers,et al.  Lipoprotein fractionation in deuterium oxide gradients: a procedure for evaluation of antioxidant binding and susceptibility to oxidation. , 1994, Journal of lipid research.

[89]  D. Rader,et al.  Markedly accelerated catabolism of apolipoprotein A-II (ApoA-II) and high density lipoproteins containing ApoA-II in classic lecithin: cholesterol acyltransferase deficiency and fish-eye disease. , 1994, The Journal of clinical investigation.

[90]  A. Damião,et al.  [Chylomicron metabolism]. , 1989, Revista do Hospital das Clinicas.

[91]  D. Russell,et al.  Receptor-mediated endocytosis: concepts emerging from the LDL receptor system. , 1985, Annual review of cell biology.

[92]  W. H. Heaton,et al.  Plasma apolipoprotein A-1 absence associated with a marked reduction of high density lipoproteins and premature coronary artery disease. , 1982, Arteriosclerosis.